Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday1Y Return

REGNRegeneron Pharmaceuticals Inc− 1.38%+ 44.24%
ABBVAbbVie Inc− 1.43%+ 20.91%
AMGNAmgen Inc− 1.53%+ 52.28%

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

REGN+ 44.2%ABBV+ 20.9%AMGN+ 52.3%Tap or hover the chart for values along the way

Metric	REGNRegeneron Pharmaceuticals Inc	ABBVAbbVie Inc	AMGNAmgen Inc
Return
Last Price	831.87	256.49	437.32
Daily Change	− 1.38%	− 1.43%	− 1.53%
Period ReturnPast Year	+ 44.24%	+ 20.91%	+ 52.28%
Valuation
Market Cap	$87.2 B	$453 B	$236 B
P/E Ratio	—	72.06	27.16
Dividend Yield	—	4.47%	3.21%
Net MarginTrailing 12M	—	9.8%	23.0%
Risk
Beta	—	0.20	0.45
52-Week Range	—	190.75 — $267.47	269.77 — $447.03
Company
Sector	Health Care	Health Care	Health Care
Industry	Biotechnology	Biotechnology	Biotechnology

Company

REGNHealth Care · Biotechnology
ABBVHealth Care · Biotechnology
AMGNHealth Care · Biotechnology

Metrics could not be loaded for REGN: P/E, dividend, beta and the 52-week range stay empty in that column.

FinnhubUpdated 21:53

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.